Eliem Therapeutics
Eliem is a Washington-based biotechnology firm that develops and commercializes novel therapies for the treatment of nervous system disorders.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Eliem Therapeutics Information
Geographic Data
Address: 23515 NE Novelty Hill Road
City: Redmond
State: WA
Zip: 98053
Country: US
Financial Info
Stage:
series b
Raised Last:
$60M
Raised Total:$171M
Social
Metrics
6,948,400Website Global Rank
677Website Monthly Traffic
Twitter Followers
Description
Eliem is a Washington-based biotechnology firm that develops and commercializes novel therapies for the treatment of nervous system disorders.
Contact Phone:
+14252762300
Contact Email:
Eliem Therapeutics went public on 8/10/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/10/2021
IPO Valuation:
$317M
Ticker Symbol:
ELYM
IPO Price:
$12.5/share
Amount Raised:
$80M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
